05-04-2019, 06:43 AM
(This post was last modified: 05-04-2019, 06:51 AM by chuck white. Edited 1 time in total.)
Quote:A number of recent publications from Henan University, Kaifeng, China contribute to the story in relation to bismuth thisosemicarbazone or thiocarbonohydrazone complexes as anti-cancer agents [19,91,92,93,94]. As previously mentioned, in relation to the development of Bi-based anti-bacterial agents
https://www.mdpi.com/1420-3049/19/9/1525...s-19-15258
Quote:Exposure of Y. enterocolitica 808lc to Pepto-Bismol for as brief a time as 5 min was sufficient to produce the inhibitory effect. Removal of bismuth bound to bacteria by sodium potassium tartrate did not reverse the inhibition. Electron-dense deposits are observed in Y. enterocolitica 808lc exposed to bismuth subsalicylate, suggesting that interference of invasion may result from bismuth permeation of the bacterial cell wall.
https://link.springer.com/article/10.1007/BF00202053